<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000367444">
  <TermName>epothilone D</TermName>
  <TermPronunciation>(eh-POTH-ih-lone ...)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of mitotic inhibitor and epothilone. Also called KOS-862.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000711699" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epothilone D&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000711698" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epotilona D&quot;" language="es" id="_4"/>
  <SpanishTermName>epotilona D</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor mitótico y de epotilona. También se llama KOS-862.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-04-23</DateFirstPublished>
  <DateLastModified>2007-03-19</DateLastModified>
</GlossaryTerm>
